The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death

Hepatology

Volumn 24, Issue 4 I, 1996, Pages 820-823

  Merkel, Carlo ^a,c   Marchesini, Giulio ^b   Fabbri, Andrea ^b   Bianco, Simone ^a   Bianchi, Giampaolo ^b   Enzo, Edda ^a   Sacerdoti, David ^a   Zoli, Marco ^b   Gatta, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Istituto di Medicina Clinica Padova   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LIVER METABOLISM; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0029811058     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008855183     Document Type: Article

References (18)

1. Boissel JP, Collet JP, Moleur P, Haugh M. Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol 1992;43:235-244.
2. Fleming TR, Prentice RL, Pepe MS, Glidden D. Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research. Stat Med 1994;13:955-969.
3. Herson J. The use of surrogate endpoints in clinical trials (an introduction to a series of four papers). Stat Med 1989;8:403-404.
4. Prentice RL. Surrogate endpoints in clinical trials: definitions and operational criteria. Stat Med 1989;8:431-440.
5. Reichen J, Solioz M, Buehler H, Gonvers JJ, Knoblauch M, Lavanchy D, Male PJ, et al. Low-dose interferon in chronic hepatitis non-A/non-B: effects on quantitative liver function and structure in a randomized controlled multicenter trial. Clin Investigator 1993;71:888-893.
6. Merkel C, Bolognesi M, Bellon S, Bianco S, Honisch B, Lampe H, Angeli P, et al. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 1992;33:836-842.
7. Merkel C, Gatta A, Zoli M, Bolognesi M, Angeli P, Iervese T, Marchesini G, et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci 1991;36:1197-1203.
8. Reichen J, Widmer T, Cotting J. Accurate prediction of death by serial determinations of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model. HEPATOLOGY 1991;14:504-510.
9. Marchesini G, Fabbri A, Bugianesi E, Bianchi GP, Marchi E, Zoli M, Pisi E. Analysis of the deterioration rates of liver function in cirrhosis, based on galactose elimination capacity. Liver 1990;10:65-71.
10. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest 1966;18(suppl):118-125.
11. Christensen E, Schlichting P, Fauerholdt L, Juhl E, Poulsen H, Tygstrup N. Changes in laboratory variables with time in cirrhosis: prognostic and therapeutic significance. HEPATOLOGY 1985;5:843-853.
12. Kaplan EL, Meier P. Nonparametric estimates from incomplete observations. J Am Stat Assoc 1958;53:457-481.
13. Lin DY, Fischl MA, Schoenfeld DA. Evaluation of the role of CD4-lymphocite count as surrogate endpoints in human immunodeficiency virus clinical trials. Stat Med 1993;12:835-842.
14. Cox DR. Regression models and life tables (with discussion). J Royal Stat Soc 1972;B34:187-220.
15. Christensen E, Schlichting P, Andersen PK, Fauereholdt L, Schou G, Pedersen BV, Juhl E, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986;71:163-174.
16. Powell WJ Jr, Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Am J Med 1968;44:406-416.
17. Brunt PW, Kew MC, Scheuer PJ, Sherlock S. Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history. Gut 1974;15:52-65.
18. Freedman LS, Graubard BI, Schatzkin A. Statistical validation of intermediate endpoints for chronic diseases. Stat Med 1992;11:167-178.